The Safety and Efficacy of Roflumilast Foam in HS

Abroad (travel likely)RecruitingPHASE2

Conditions

Hidradenitis Suppurativa (HS)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Contact: Study coordinator (Martina Porter, MD) · clears@bidmc.harvard.edu · 6176675834

Study leads

Martina Porter, MD
Principal Investigator
Beth Israel Deaconess Medical Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

Hidradenitis Suppurativa (HS)

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Phoenix, United States

A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.

Hidradenitis Suppurativa

Abroad (travel likely)RecruitingPHASE2

Phoenix, United States · Phoenix, United States

A Study With CIT-013 in HS Patients

Hidradenitis Suppurativa (HS)

Abroad (travel likely)RecruitingPHASE2

Barrie, Canada · Calgary, Canada

Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis Suppurativa

Hidradenitis Suppurativa (HS)

Abroad (travel likely)RecruitingPHASE2

Samsun, Turkey (Türkiye)